Fred Alger Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,564	Closed	-$1.13M	–	486
2024 Q2	$1.13M	Buy	16,564 +4,030	+32%	+$280K	0.01%	353
2024 Q1	$867K	Buy	+12,534	New	+$861K	﹤0.01%	376
2022 Q4	–	Sell	-38,536	Closed	-$1.79M	–	577
2022 Q3	$1.79M	Sell	38,536 -46,184	-55%	-$2.41M	0.01%	350
2022 Q2	$4.84M	Sell	84,720 -21,008	-20%	-$1.19M	0.02%	267
2022 Q1	$6.47M	Buy	+105,728	New	+$5.49M	0.02%	250
2017 Q4	–	Sell	-20,000	Closed	-$316K	–	598
2017 Q3	$316K	Buy	20,000 +7,000	+54%	+$103K	﹤0.01%	371
2017 Q2	$161K	Buy	+13,000	New	+$151K	﹤0.01%	393
2016 Q3	–	Sell	-5,200	Closed	-$202K	–	541
2016 Q2	$202K	Buy	+5,200	New	+$187K	﹤0.01%	415
2015 Q4	–	Sell	-6,700	Closed	-$268K	–	596
2015 Q3	$268K	Sell	6,700 -25,750	-79%	-$840K	﹤0.01%	460
2015 Q2	$1.04M	Sell	32,450 -132,347	-80%	-$3.36M	﹤0.01%	425
2015 Q1	$3.94M	Buy	+164,797	New	+$3.69M	0.02%	367